Positioning versus practice depth: a women-focused storefront on a mass telehealth platform, against a specialist clinic whose pitch is the clinician, not the demographic.
The two models
Hers is Hims’ women-focused sibling, sharing the platform, the post-Novo compounded “personalization” posture, and the aggressive entry pricing — wrapped in women’s-health positioning. The same questions apply: maintenance-dose truth, fee stack, and legal lane, all pending verification in our queue.
Mochi Health is the obesity-medicine specialist play: board-certified obesity clinicians on a membership model, with medication costs separate. It’s the structural bet that care depth — titration judgment, comorbidity management — is worth paying for distinctly. Membership-plus-medication totals are queued for verification.
Verified vs pending — read this before the marketing
Neither provider on this page has completed price verification, so this comparison stays structural — business models, pricing architecture, and the questions each must answer — with zero advertised numbers repeated as facts. The only verified figures on this site today sit in the ledger.
For the reader both are courting
A woman navigating PCOS, perimenopause, or contraception questions alongside weight treatment is exactly who both brands address — one through marketing focus, one through obesity-medicine specialists who handle those intersections clinically. The evidence she actually needs sits in our PCOS and fertility files either way; what the two programs charge for their respective wrappers is pending verification, and until then the wrappers are the whole comparison.
Go deeper
Full files: Hers · Mochi Health. Decision tools: the quiz routes by coverage and priorities; the calculator turns any quote into a true 12-month number; the ledger holds every verified figure and every pending slot.